| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
71,130 |
62,983 |
$3.89M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
22,897 |
15,143 |
$2.08M |
| G6015 |
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session |
6,500 |
1,159 |
$1.42M |
| 99215 |
Prolong outpt/office vis |
13,941 |
11,426 |
$1.05M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
187 |
132 |
$673K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,325 |
16,603 |
$660K |
| 77014 |
|
7,025 |
1,293 |
$480K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,684 |
4,554 |
$440K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
412 |
382 |
$279K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
2,686 |
1,695 |
$274K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,876 |
1,785 |
$251K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,825 |
7,443 |
$240K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,222 |
799 |
$193K |
| G9678 |
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement |
1,055 |
1,021 |
$191K |
| 77427 |
|
1,561 |
824 |
$187K |
| 96367 |
|
5,509 |
3,451 |
$179K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,711 |
1,624 |
$136K |
| J0897 |
Injection, denosumab, 1 mg |
113 |
102 |
$128K |
| 77336 |
|
1,756 |
880 |
$87K |
| 99233 |
Prolong inpt eval add15 m |
1,284 |
573 |
$83K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,367 |
5,437 |
$80K |
| 51798 |
|
9,435 |
8,825 |
$78K |
| 99223 |
Prolong inpt eval add15 m |
643 |
598 |
$73K |
| 52000 |
|
612 |
580 |
$73K |
| 99205 |
Prolong outpt/office vis |
486 |
479 |
$59K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
914 |
630 |
$49K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,038 |
2,872 |
$46K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,113 |
809 |
$45K |
| 96417 |
|
771 |
500 |
$43K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
404 |
369 |
$31K |
| 77301 |
|
29 |
25 |
$29K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
57 |
57 |
$24K |
| 77300 |
|
192 |
171 |
$22K |
| 77334 |
|
164 |
108 |
$21K |
| 52356 |
|
68 |
63 |
$21K |
| 36591 |
|
1,017 |
821 |
$19K |
| 77338 |
|
74 |
64 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,855 |
2,007 |
$18K |
| G6012 |
Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev |
82 |
25 |
$17K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
261 |
245 |
$16K |
| 96415 |
|
478 |
322 |
$15K |
| 77280 |
|
86 |
38 |
$14K |
| 77263 |
|
102 |
97 |
$12K |
| 50590 |
|
19 |
17 |
$11K |
| 51784 |
|
356 |
258 |
$11K |
| G6013 |
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev |
62 |
12 |
$10K |
| 99222 |
Initial hospital care, per day, moderate complexity |
135 |
125 |
$10K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,382 |
5,066 |
$9K |
| G6017 |
Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment |
117 |
24 |
$9K |
| J3490 |
Unclassified drugs |
709 |
370 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
362 |
316 |
$8K |
| 96523 |
|
264 |
214 |
$6K |
| G6002 |
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy |
83 |
13 |
$6K |
| 51728 |
|
26 |
25 |
$6K |
| 87481 |
|
55 |
55 |
$5K |
| 74420 |
|
272 |
234 |
$5K |
| 76857 |
|
160 |
156 |
$4K |
| 96411 |
|
96 |
66 |
$4K |
| J9190 |
Injection, fluorouracil, 500 mg |
77 |
52 |
$4K |
| J1750 |
Injection, iron dextran, 50 mg |
12 |
12 |
$4K |
| 87653 |
|
71 |
70 |
$2K |
| 87640 |
|
71 |
70 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
71 |
70 |
$2K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
55 |
37 |
$2K |
| 77470 |
|
30 |
28 |
$2K |
| 91122 |
|
15 |
12 |
$2K |
| 51797 |
|
29 |
27 |
$2K |
| J1756 |
Injection, iron sucrose, 1 mg |
28 |
15 |
$1K |
| 52332 |
|
17 |
14 |
$1K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
254 |
132 |
$1K |
| 46600 |
|
13 |
13 |
$1K |
| 97750 |
|
49 |
39 |
$1K |
| 96368 |
|
70 |
50 |
$986.98 |
| 99442 |
|
15 |
15 |
$896.35 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
359 |
326 |
$499.36 |
| 57420 |
|
22 |
13 |
$496.45 |
| 51700 |
|
20 |
19 |
$398.58 |
| 97032 |
|
47 |
37 |
$366.76 |
| 51741 |
|
41 |
40 |
$299.97 |
| 96127 |
|
67 |
65 |
$281.30 |
| 81002 |
|
153 |
148 |
$258.02 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14 |
12 |
$250.34 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
409 |
246 |
$221.48 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
65 |
37 |
$125.25 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
12 |
$101.31 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
14 |
14 |
$53.71 |
| J7050 |
Infusion, normal saline solution, 250 cc |
31 |
26 |
$18.69 |